Oncologists discuss the indication, structure, and mechanism of delivery of ONIVYDE®, a unique liposomal formulation of irinotecan.1
Intended for healthcare professionals
The information within this site is intended for US healthcare professionals only.
Please choose an option below to continue.
NCCN makes no warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way.
YOU ARE NOW LEAVING ONIVYDE.COM
You are about to leave ONIVYDE.com and visit a third-party website. The website will load automatically unless you click Cancel.